Professor Michael Barry:

I think it does. Some people have looked at these thresholds to see whether they are correct or whether they should be higher or lower, but it gives us something to aim for in terms of value. We then negotiate on that.

The drugs reimbursed by the HSE this year will not all reach the €45,000 threshold. Some will be below it and some will be above it, but it is an indicative target.